SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-21-004988
Filing Date
2021-03-31
Accepted
2021-03-31 16:02:59
Documents
3
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp148814_6k.htm 6-K 14400
2 EXHIBIT 99.1 dp148814_ex9901.htm EX-99.1 62740
3 GRAPHIC logo.jpg GRAPHIC 7237
  Complete submission text file 0000950103-21-004988.txt   88470
Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Filer) CIK: 0001810031 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39431 | Film No.: 21793200
SIC: 2836 Biological Products, (No Diagnostic Substances)